- Home
- INBX vs MLAB Comparison
INBX vs MLAB Comparison
Compare INBX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- MLAB
- Stock Information
- Founded
- INBX 2010
- MLAB 1982
- Country
- INBX United States
- MLAB United States
- Employees
- INBX N/A
- MLAB N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- INBX Health Care
- MLAB Industrials
- Exchange
- INBX Nasdaq
- MLAB Nasdaq
- Market Cap
- INBX 430.2M
- MLAB 441.2M
- IPO Year
- INBX 2020
- MLAB N/A
- Fundamental
- Price
- INBX $83.93
- MLAB $70.47
- Analyst Decision
- INBX Hold
- MLAB Hold
- Analyst Count
- INBX 2
- MLAB 1
- Target Price
- INBX N/A
- MLAB $67.00
- AVG Volume (30 Days)
- INBX 458.6K
- MLAB 147.7K
- Earning Date
- INBX 11-14-2025
- MLAB 11-06-2025
- Dividend Yield
- INBX N/A
- MLAB 0.91%
- EPS Growth
- INBX N/A
- MLAB N/A
- EPS
- INBX N/A
- MLAB N/A
- Revenue
- INBX $1,400,000.00
- MLAB $245,255,000.00
- Revenue This Year
- INBX $563.00
- MLAB $5.38
- Revenue Next Year
- INBX $230.77
- MLAB $5.25
- P/E Ratio
- INBX N/A
- MLAB N/A
- Revenue Growth
- INBX N/A
- MLAB 7.39
- 52 Week Low
- INBX $10.81
- MLAB $55.45
- 52 Week High
- INBX $86.64
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- INBX 71.64
- MLAB 45.27
- Support Level
- INBX $79.05
- MLAB $69.51
- Resistance Level
- INBX $85.75
- MLAB $73.97
- Average True Range (ATR)
- INBX 6.92
- MLAB 3.91
- MACD
- INBX -0.97
- MLAB -0.81
- Stochastic Oscillator
- INBX 81.14
- MLAB 17.57
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.